AbstractPURPOSE:: To evaluate the safety and efficacy of treatment of severe infectious corneal ulcers with hypoosmolar riboflavin solution and UV-A collagen cross-linking (CXL) without deepithelizing the cornea. METHODS:: Four eyes of 3 patients with severe keratitis and associated corneal melting, were treated with a new protocol of corneal CXL for infectious keratitis, named cross-linking window absorption (CXL-WA). CXL-WA was performed when the infection did not respond to systemic and topical antibiotic therapy. The protocol entails the use of hypoosmolar riboflavin before the irradiation with UV-A, and the penetration is obtained through the epithelial defect overlying the ulcer. RESULTS:: In all cases, CXL halted the progression of the ulcer. After a minimum follow-up of 3 months, none of the patients had recurrence of the infection. CONCLUSION:: CXL-WA is a promising technique of treatment of infectious corneal ulcers, delaying or preventing more invasive approaches. Copyright © 2012 by Lippincott Williams Wilkins.--------------------------------------------------------------------------------Reaxys Database Information|
Corneal Collagen Cross-Linking Window Absorption
Mario Romano;Vinciguerra P.
2013-01-01
Abstract
AbstractPURPOSE:: To evaluate the safety and efficacy of treatment of severe infectious corneal ulcers with hypoosmolar riboflavin solution and UV-A collagen cross-linking (CXL) without deepithelizing the cornea. METHODS:: Four eyes of 3 patients with severe keratitis and associated corneal melting, were treated with a new protocol of corneal CXL for infectious keratitis, named cross-linking window absorption (CXL-WA). CXL-WA was performed when the infection did not respond to systemic and topical antibiotic therapy. The protocol entails the use of hypoosmolar riboflavin before the irradiation with UV-A, and the penetration is obtained through the epithelial defect overlying the ulcer. RESULTS:: In all cases, CXL halted the progression of the ulcer. After a minimum follow-up of 3 months, none of the patients had recurrence of the infection. CONCLUSION:: CXL-WA is a promising technique of treatment of infectious corneal ulcers, delaying or preventing more invasive approaches. Copyright © 2012 by Lippincott Williams Wilkins.--------------------------------------------------------------------------------Reaxys Database Information|File | Dimensione | Formato | |
---|---|---|---|
Corneal-collagen-cross-linking-window-absorption_2013_Cornea.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
384.92 kB
Formato
Adobe PDF
|
384.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.